Literature DB >> 25701049

Utility of Platelet Count for Predicting Cirrhosis in Alcoholic Liver Disease: Model for Identifying Cirrhosis in a US Population.

Arvind R Murali1, Bashar M Attar, Ariel Katz, Vikram Kotwal, Peter M Clarke.   

Abstract

BACKGROUND: Thrombocytopenia has been shown to be the single most useful laboratory investigation for identifying subclinical cirrhosis of varying etiologies. However, alcohol per se can result in thrombocytopenia, and hence it is unclear whether platelet count can identify cirrhosis in patients who are alcoholic.
OBJECTIVES: To characterize the utility of clinical predictors, especially platelet count, for identifying the presence of cirrhosis in alcoholics. To develop a simple, objective model for identifying cirrhosis in alcoholics.
DESIGN: Retrospective cohort study. PARTICIPANTS: A total of 2,471 consecutive hospitalized patients with abnormal liver enzyme levels were screened, from which 272 patients with a history of recent and ongoing alcohol intake, negative diagnostic studies for alternative etiologies of chronic liver disease, and recent liver imaging with ultrasound or CT scan were included. MAIN MEASURES: Results of liver imaging and admission laboratory studies including liver enzymes, coagulation studies, and blood counts. KEY
RESULTS: One hundred twenty-nine patients (47%) had cirrhosis based on imaging; 143 patients (53%) had no cirrhosis. A pre-sobriety platelet count (during ongoing alcohol intake) of less than 70*10(3) cells/mm(3) was effective for ruling in cirrhosis (positive likelihood ratio [LR] 6.8, 95% CI: 3.4, 14); platelet count greater than 200*10(3) was useful for ruling out cirrhosis in alcoholics (negative LR 0.18, 95% CI: 0.10, 0.35). Multivariate logistic regression analysis identified international normalized ratio (INR) (p < 0.01) and pre-sobriety platelet count (p < 0.01) as independent predictors of cirrhosis. A Model for identifying Cirrhosis in Alcoholic Liver Disease (MCALD) was developed using the INR and pre-sobriety platelet count; it had an area under the receiver operating characteristic curve of 0.89 and Hosmer-Lemeshow goodness of fit chi(2) (p value) of 8.9 (0.35) for predicting cirrhosis in alcoholics. A MCALD score > 5.5 corresponded to an increased likelihood of cirrhosis (LR: 6.5, 95% CI: 4.3, 11.0) and a MCALD score < 5.5 corresponded to decreased likelihood of cirrhosis in alcoholics (LR: 0.25, 95% CI: 0.19, 0.36). Sobriety platelet count (after alcohol abstinence) at a cutoff of 160*10(3) had positive LR of 7.9 (95% CI: 4.4, 14) and negative LR of 0.42 (95% CI: 0.34, 0.52) for predicting cirrhosis in alcoholics.
CONCLUSIONS: A simple model of platelet count and INR has good diagnostic accuracy for identifying cirrhosis in alcoholics.

Entities:  

Mesh:

Year:  2015        PMID: 25701049      PMCID: PMC4510215          DOI: 10.1007/s11606-015-3238-1

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  12 in total

1.  The diagnosis of cirrhosis by high resolution ultrasound of the liver surface.

Authors:  V Simonovský
Journal:  Br J Radiol       Date:  1999-01       Impact factor: 3.039

2.  FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C.

Authors:  Masahiko Koda; Yoshiko Matunaga; Manri Kawakami; Yukihiro Kishimoto; Takeaki Suou; Yoshikazu Murawaki
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

3.  Liver biopsy.

Authors:  Don C Rockey; Stephen H Caldwell; Zachary D Goodman; Rendon C Nelson; Alastair D Smith
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

4.  Likelihood ratios with confidence: sample size estimation for diagnostic test studies.

Authors:  D L Simel; G P Samsa; D B Matchar
Journal:  J Clin Epidemiol       Date:  1991       Impact factor: 6.437

5.  Deaths: preliminary data for 2011.

Authors:  Donna L Hoyert; Jiaquan Xu
Journal:  Natl Vital Stat Rep       Date:  2012-10-10

6.  Thrombocytopenia in alcoholics.

Authors:  J Lindenbaum; R L Hargrove
Journal:  Ann Intern Med       Date:  1968-03       Impact factor: 25.391

7.  Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis.

Authors:  Charles S Lieber; David G Weiss; Timothy R Morgan; Fiorenzo Paronetto
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

8.  Does this patient with liver disease have cirrhosis?

Authors:  Jacob A Udell; Charlie S Wang; Jill Tinmouth; J Mark FitzGerald; Najib T Ayas; David L Simel; Michael Schulzer; Edwin Mak; Eric M Yoshida
Journal:  JAMA       Date:  2012-02-22       Impact factor: 56.272

9.  Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies.

Authors:  F Piccinino; E Sagnelli; G Pasquale; G Giusti
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

Review 10.  Global burden of alcoholic liver diseases.

Authors:  Jürgen Rehm; Andriy V Samokhvalov; Kevin D Shield
Journal:  J Hepatol       Date:  2013-03-16       Impact factor: 25.083

View more
  3 in total

1.  Development of a model based on biochemical, real‑time tissue elastography and ultrasound data for the staging of liver fibrosis and cirrhosis in patients with chronic hepatitis B.

Authors:  Shi-Hao Xu; Qiao Li; Yuan-Ping Hu; Li Ying
Journal:  Mol Med Rep       Date:  2016-08-26       Impact factor: 2.952

2.  Intracranial Hemorrhage in Methanol Toxicity: Challenging the Probable Heparin Effect during Hemodialysis.

Authors:  Hossein Hassanian-Moghaddam; Hooman Bahrami-Motlagh; Nasim Zamani; Seyed Amirhossein Fazeli; Behdad Behnam
Journal:  J Res Pharm Pract       Date:  2017 Jul-Sep

3.  Risk of reduced platelet counts in patients with nonalcoholic fatty liver disease (NAFLD): a prospective cohort study.

Authors:  Fang Liu; Hui Zhou; Lei Cao; Zhirong Guo; Chen Dong; Lugang Yu; Yiying Wang; Chunxing Liu; Jing Qiu; Yong Xue; Xingxiang Liu; Yunfang Xu
Journal:  Lipids Health Dis       Date:  2018-09-19       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.